Innate immune sensing by RIG-I-like receptors (RLRs) and the cGAS-STING pathway is tightly regulated by glycosylation. This review summarizes how distinct glycosylation modalities shape antiviral signaling at multiple levels. N-glycosylation in the ER-Golgi is essential for STING folding, stability, and signaling competence, whereas aberrant glycan states disrupt DNA sensing. In contrast, cytosolic O-GlcNAcylation dynamically modulates RLR-cGAS pathways by regulating MAVS aggregation, suppressing IRF3 and NF-κB activation, and interfering with cGAS-DNA binding. We further discuss crosstalk between glycosylation, ubiquitination, and phosphorylation, metabolic regulation of UDP-GlcNAc flux, and pathogen- or tumor-driven glycosylation reprogramming, highlighting glycosylation enzymes as potential immunomodulatory targets. The authors review the role of glycosylation and its subtypes in DNA and RNA-sensing pathways within host innate immunity.
Tong et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: